Mark B. Taubman, M.D.

Mark B. Taubman, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 706
Rochester, NY 14642

Appointment: (585) 275-2475

  • Accepting New Patients Accepting New Patients
  • Admits to Strong Memorial Hospital Admits to Strong Memorial Hospital
  • Admits to Highland Hospital Admits to Highland Hospital

Professional Bio

Dr. Taubman is CEO of the Medical Center, Dean of the School of Medicine and Dentistry, and Senior Vice President for Health Sciences at the University of Rochester. He received his M.D. degree from New York University and completed his training in medicine and cardiology at the Brigham and Women's Hospital and Harvard Medical School. He has served on the faculties of Mt. Sinai School of Medicine in New York, Children's Hospital Medical Center and Harvard Medical School in Boston, Massachusetts. Dr. Taubman was previously the Charles E. Dewey Professor and Chairman of Medicine (2007-2010) and Chief of the Cardiology Division (2003-2009) at the University of Rochester. In addition he was Director of the Aab Cardiovascular Research Institute (2005-2007) and Director of the Center for Cellular and Molecular Cardiology (2003-2005). Dr. Taubman is a member of the American Heart Association, the American Society of Hypertension, the Association of University Cardiologists, and the Association of American Medical Colleges. He is a Fellow, American College of Cardiology and Fellow, American College of Physicians. He is the former Editor-in-Chief, Arteriosclerosis, Thrombosis, and Vascular Biology.



Dr. Taubman is an international authority in vascular biology with research interests in tissue factor biology and chemokines. He has published widely – more than 120 articles, chapters, and books.

Patient Care Bio

Dr. Mark Taubman serves as the Charles A. Dewey Professor and Chairman of Medicine at the University of Rochester School of Medicine and Dentistry. He is certified by the American Board of Internal Medicine in both Internal Medicine and Cardiovascular Disease.

Dr. Taubman received his medical degree at the New York University School of Medicine. He completed his residency in Internal Medicine at Brigham & Women's Hospital in Boston, Massachusetts, and completed fellowships in Cardiology at Brigham & Women's Hospital and Boston Children's Hospital. Prior to coming to the University of Rochester, Dr. Taubman served as Professor of Medicine at the Mount Sinai School of Medicine in New York City

Awards & Honors (Local)

Alpha Omega Alpha 2004
Special Recognition Award, Council on Arteriosclerosis, Thrombosis, and Vascular Biology 2002
Distinguished Research Award, Department of Medicine, Mount Sinai School Of Medicine 1996
Irma T. Hirschl Award "Isolation and characterization of genes regulating blood vessel growth 1991 - 1995
NIH Clinical Investigator Award "Vascular smooth muscle cDNA contractile protein clones" Boston Children's Hospital, Boston, MA 1984 - 1989
NIH Institutional Training Grant for Cardiovascular Research Brigham & Women's Hospital, Boston, MA 1983 - 1984
NIH Training Grant Medical Scientist Training Program, New York University School of Medicine, New York, NY 1972 - 1978

Patents

Tissue Factor Pathway Inhibition as a Treatment Strategy for Severe Pulmonary Arterial Hypertension

United States Serial NO.: 11/576,773
Filed Date: October 7, 2005
Title: Treatment of Pulmonary Hylertension uisng An Agent that Inhibits a Tissue Factor Pathway
Invented by: R. James White, Mark Taubman
Tissue Factor Pathway Inhibition as a Treatment Strategy for Severe Pulmonary Arterial Hypertension

United States Serial NO.: FR05813918.9
Filed Date: October 6, 2005
Title: Treatment of Pulmonary Hylertension uisng An Agent that Inhibits a Tissue Factor Pathway
Invented by: R. James White, Mark Taubman
Tissue Factor Pathway Inhibition as a Treatment Strategy for Severe Pulmonary Arterial Hypertension

United States Serial NO.: DE05813918.9
Filed Date: October 6, 2005
Title: Treatment of Pulmonary Hylertension uisng An Agent that Inhibits a Tissue Factor Pathway
Invented by: R. James White, Mark Taubman
Tissue Factor Pathway Inhibition as a Treatment Strategy for Severe Pulmonary Arterial Hypertension

United States Serial NO.: GB05813918.9
Filed Date: October 6, 2005
Title: Treatment of Pulmonary Hylertension uisng An Agent that Inhibits a Tissue Factor Pathway
Invented by: R. James White, Mark Taubman

Current Appointments

Dean, School of Medicine & Dentistry - Department of Dean's Office, SMD (SMD) - Primary Administrative
CEO, University of Rochester Medical Center - Department of Office of VP for Health Sciences (URMC) - Primary Administrative
Professor - Department of Medicine, Cardiology (SMD) - Primary

Specialties

Internal Medicine - American Board of Internal Medicine
Cardiovascular Disease - American Board of Internal Medicine

Education

MD | Medicine | New York Univ Sch Medicine1978
MS | Pre-Medical | New York Univ Sch Medicine1976
BA | Biochemistry | Columbia University1972

Post-Doctoral Training & Residency

Research in Cardiology at Children s Hospital07/01/1984 - 06/30/1989
Fellowship in Cardiovascular Disease at Brigham and Women's Hospital07/01/1981 - 06/30/1983
Residency in Internal Medicine at Brigham and Women's Hospital07/01/1979 - 06/30/1981
Internship in Internal Medicine at Brigham and Women's Hospital07/01/1978 - 06/30/1979